Showing results (671-680 of 837) with videos related to
Sort By:
Pageof 84
Birth Defects Research|March 21, 2023
Maternal dietary caffeine consumption and risk of birth defects in the National Birth Defects Prevention Study, 1997-2011Eva M Williford, Meredith M Howley, Sarah C Fisher, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 15, 2005
Monitoring left ventricular dilation in mice with PETLars Stegger, Klaus P Schäfers, Ulrich Flögel, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 7, 2007
Alpha-actinin-3 (ACTN3) R577X polymorphism influences knee extensor peak power response to strength training in older men and womenMatthew J Delmonico, Matthew C Kostek, Neil A Doldo, et al.Extremophiles : Life Under Extreme Conditions|May 26, 2018
Native xylose-inducible promoter expands the genetic tools for the biomass-degrading, extremely thermophilic bacterium Caldicellulosiruptor besciiAmanda M Williams-Rhaesa, Nanaakua K Awuku, Gina L Lipscomb, et al.JNCI Cancer Spectrum|August 9, 2019
Incidence and Survival Among Young Women With Stage I-III Breast Cancer: SEER 2000-2015Alexandra Thomas, Anthony Rhoads, Elizabeth Pinkerton, et al.Current Therapeutic Research, Clinical and Experimental|August 4, 2023
Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related TrendsXintian Lyu, Sílvia M Illamola, Susan E Marino, et al.European Journal of Immunology|December 1, 1993
Differential effect of transporter Tap 2 gene introduction into RMA-S cells on viral antigen processingM A Ossevoort, A J Sijts, K J van Veen, et al.The New England Journal of Medicine|July 11, 2019
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for MigraineRichard B Lipton, Robert Croop, Elyse G Stock, et al.Birth Defects Research|October 28, 2018
Maternal arsenic exposure and nonsyndromic orofacial cleftsJonathan Suhl, Stephanie Leonard, Peter Weyer, et al.Antiviral Therapy|June 11, 2014
Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapyLaetitia Canini, Swati DebRoy, Zoe Mariño, et al.Pageof 84